BRITTANY LEOS: Open Payments
NPI 1881273001 · CULVER CITY, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,207 in 70 payments from 7 companies in 2025. Trend: 2023 $1,612 · 2024 $1,656 · 2025 $1,207
Food & beverage: $1,207
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 30 | $412 |
| Otsuka America Pharmaceutical, Inc. | 11 | $275 |
| Alkermes, Inc. | 15 | $219 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $154 |
| Neurocrine BioSciences, Inc. | 6 | $106 |
| Vanda Pharmaceuticals Inc. | 1 | $24 |
| Lundbeck LLC | 1 | $16 |
Products named: INVEGA SUSTENNA, ABILIFY ASIMTUFII, ARISTADA, CAPLYTA, INGREZZA, ABILIFY MAINTENA, FANAPT.
Industry payments across CA — which companies pay providers there.
